Ulcerative colitis and Crohn's disease<unk>  has been approved for use in adults with moderate to severe ulcerative colitis or Crohn's disease having a poor response to tumor necrosis factor (TNF) blockers or corticosteroids, or for those who are steroid-dependent. Checkpoint inhibitor colitis<unk>  may be used to treat steroid refractory checkpoint inhibitor induced colitis, if infliximab is ineffective or contraindicated.
Vedolizumab
Mepolizumab
Nemolizumab
Certolizumab pegol
Belatacept
Natalizumab
Infliximab
Abatacept